相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interfacial Binding Sites for Cholesterol on G Protein-Coupled Receptors
Anthony G. Lee
BIOPHYSICAL JOURNAL (2019)
Second M3 muscarinic receptor binding site contributes to bronchoprotection by tiotropium
Loes E. M. Kistemaker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Does Divergent Binding Pocket Closure Drive Ligand Bias for Class A GPCRs?
Marcel Bermudez et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs
Scott A. Hollingsworth et al.
NATURE COMMUNICATIONS (2019)
Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia
Shaun Hopper et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Allosteric modulation of β-cell M3 muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice
Lu Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Crystal structure of the M5 muscarinic acetylcholine receptor
Ziva Vuckovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles
Juliana C. C. Dallagnol et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M-1 Muscarinic Acetylcholine Receptors
Emma T. van der Westhuizen et al.
MOLECULAR PHARMACOLOGY (2018)
Activation of M2 muscarinic acetylcholine receptors by a hybrid agonist enhances cytotoxic effects in GB7 glioblastoma cancer stem cells
Ilaria Cristofaro et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Role of membrane cholesterol in differential sensitivity of muscarinic receptor subtypes to persistently bound xanomeline
Alena Randakova et al.
NEUROPHARMACOLOGY (2018)
Allosteric modulators targeting CNS muscarinic receptors
Andreas Bock et al.
NEUROPHARMACOLOGY (2018)
Structure-based discovery of selective positive allosteric modulators of antagonists for the M2 muscarinic acetylcholine receptor
Magdalena Korczynska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?
Terry Kenakin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors
Wessel A. C. Burger et al.
JOURNAL OF GENERAL PHYSIOLOGY (2018)
Selective inhibition of M5 muscarinic acetylcholine receptors attenuates cocaine self-administration in rats
Barak W. Gunter et al.
ADDICTION BIOLOGY (2018)
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
Sophie J. Bradley et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors
Jan Jakubik et al.
SCIENTIFIC REPORTS (2017)
How Ligands Illuminate GPCR Molecular Pharmacology
Daniel Wacker et al.
CELL (2017)
A Photoswitchable Dualsteric Ligand Controlling Receptor Efficacy
Luca Agnetta et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor
Shailesh N. Mistry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Interaction of G protein coupled receptors and cholesterol
Gerald Gimpl
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor
Andreas Bock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
David M. Thal et al.
NATURE (2016)
Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor
Yinglong Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior
Kwok H. C. Choy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands
Marcel Bermudez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Lipid-Based Diets Improve Muscarinic Neurotransmission in the Hippocampus of Transgenic APPswe/PS1dE9 Mice
Helena Janickova et al.
CURRENT ALZHEIMER RESEARCH (2015)
Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice
Tristano Pancani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Generic GPCR residue numbers - aligning topology maps while minding the gaps
Vignir Isberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors
Pavel Michal et al.
NEUROCHEMICAL RESEARCH (2015)
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: Synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity
Carlo Matera et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor
Alaa Abdul-Ridha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mechanistic Insights into Allosteric Structure-Function Relationships at the M-1 Muscarinic Acetylcholine Receptor
Alaa Abdul-Ridha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Dualsteric Muscarinic Antagonists-Orthosteric Binding Pose Controls Allosteric Subtype Selectivity
Jens Schmitz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and Pharmacological Evaluation of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) Designed to Bind Irreversibly to an Allosteric Site of the M1 Muscarinic Acetylcholine Receptor
Briana J. Davie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols et al.
NEUROBIOLOGY OF DISEASE (2014)
Molecular Mechanisms of Methoctramine Binding and Selectivity at Muscarinic Acetylcholine Receptors
Jan Jakubik et al.
MOLECULAR PHARMACOLOGY (2014)
Discovery of the First M5-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)
Patrick R. Gentry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Ron O. Dror et al.
NATURE (2013)
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Reverse Engineering of the Selective Agonist TBPB Unveils Both Orthosteric and Allosteric Modes of Action at the M1 Muscarinic Acetylcholine Receptor
Peter Keov et al.
MOLECULAR PHARMACOLOGY (2013)
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Kazuko Haga et al.
NATURE (2012)
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2012)
Discovery of a Selective Allosteric M1 Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold
Scott D. Kuduk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structural Determinants of Allosteric Agonism and Modulation at the M4 Muscarinic Acetylcholine Receptor IDENTIFICATION OF LIGAND-SPECIFIC AND GLOBAL ACTIVATION MECHANISMS
Vindhya Nawaratne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias
Karen J. Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor
Vimesh A. Avlani et al.
MOLECULAR PHARMACOLOGY (2010)
Allosteric Modulation of Muscarinic Acetylcholine Receptors
Jan Jakubik et al.
PHARMACEUTICALS (2010)
Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways
Pavel Michal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-Trifluoromethoxy N-Benzyl Isatins
Thomas M. Bridges et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity
Joy E. Marlo et al.
MOLECULAR PHARMACOLOGY (2009)
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
P. Jeffrey Conn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND
Celine Valant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats
Ashley E. Brady et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Binding of orthosteric ligands to the allosteric site of the M2 muscarinic cholinergic receptor
Dar'ya S. Redka et al.
MOLECULAR PHARMACOLOGY (2008)
Role of the M3 muscarinic acetylcholine receptor in β-cell function and glucose homeostasis
D. Gautam et al.
DIABETES OBESITY & METABOLISM (2007)
Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M1 and M2 muscarinic acetylcholine receptors
Jan Jakubik et al.
MOLECULAR PHARMACOLOGY (2006)
Muscarinic receptor signaling in the pathophysiology of asthma and COPD
Reinoud Gosens et al.
RESPIRATORY RESEARCH (2006)
Muscarinic receptors in the bladder: from basic research to therapeutics
SS Hegde
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor:: More similarities than differences between the structurally divergent agents gallamine and bis(ammonio) alkane-type hexamethylene-bis[dimethyl-(3-phthalimidopropyl)ammonium]dibromide
XP Huang et al.
MOLECULAR PHARMACOLOGY (2005)
Asparagine, valine, and threonine in the third extracellular loop of muscarinic receptor have essential roles in the positive cooperativity of strychnine-like allosteric modulators
J Jakubík et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors:: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems
DP Zlotos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission:: relevance to the pathophysiology and treatment of related central nervous system pathologies
ET Tzavara et al.
FASEB JOURNAL (2004)
Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in M3 muscarinic acetylcholine receptor-deficient mice
A Duttaroy et al.
DIABETES (2004)
Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors
E Hermans
PHARMACOLOGY & THERAPEUTICS (2003)
Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors
S Lazareno et al.
MOLECULAR PHARMACOLOGY (2002)
Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors
J Jakubik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
